Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Aurobindo Pharma Ltd.

  • NSE: AUROPHARMA

  • BSE: 524804

  • Q
  • V
  • T
  • Mid-range Performer
92.35/100

Quality Score

High Financial Strength
31.83/100

Valuation Score

Mid Valuation
55.92/100

Technical Score

Technically Neutral
Broker Average Rating

4.00

Broker Average Rating

MFI

57.97

MFI is mid-range

50Day SMA Rs

836.70 Rs

Price below SMA-50

Quality score

92.35

High Financial Strength

30Day SMA Rs

821.41 Rs

Price below SMA-30

Broker Covering stock

11.00

11 Broker Covering stock

Broker 6M Target upgrade

17.00

17 Broker 6M Target upgrade

Broker 6M Target downgrade

4.00

4 Broker 6M Target downgrade

Momentum score

55.92

Technically Neutral

Price to Book Ratio

2.78

Above industry Median

Broker Reports in 1Yr

48.00

48 Broker Reports in 1Yr

TTM PE Ratio

15.52

Below industry Median

Broker 6M Reco upgrade

4.00

4 Broker 6M Reco upgrade

RSI

47.82

RSI is mid-range

Net Profit Qtr Cr

792.68 Cr

Market Leader

AVG Broker Target

20.58 %

20.58% upside

Operating Revenues Qtr Cr

5924.78 Cr

Market Runner Up

MACD

-15.78

MACD below Signal and Center

Valuation score

31.83

Mid Valuation

MACD Signal Line

-13.93

MACD below Signal and Center

FII holding holding %

22.63 %

FII holding increased by 0.37%.

Promoter holding holding %

52.01 %

No change in Promoter holding

MF holding holding %

12.20 %

MF holding increased by 0.25%.

Broker 6M Reco downgrade

4.00

4 Broker 6M Reco downgrade

100Day SMA Rs

798.53 Rs

price crossed below SMA100 today

Institutions holding holding %

35.19 %

Institutions holding increased by 0.37%.

AVG Broker Target

960.45 Rs

20.58% upside

200Day SMA Rs

644.68 Rs

Price above SMA 644.68

NSE AUROPHARMA
796.55
  • 800.70 Close
  • 805.00 Open
  • 31.07 Lk Volume
Today Low/High
Low 790.35
High 809.90
52 Week Low/High
23-03-2020 288.85
10-08-2020 967.50

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Aurobindo Pharma Ltd. 796.55 15.52 46669.86 0.53 792.68 0 5924.78 8.81 2.77
Sun Pharmaceutical Industries Ltd. 506.15 475.11 121440.56 0.79 -2429.81 0 7585.25 -9.43 2.47
Dr. Reddy's Laboratories Ltd. 5084.2 44.55 84499.4 0.49 586.9 0 4426.5 14.72 5.42
Divi's Laboratories Ltd. 3061.9 50.92 81278.13 0.52 492.06 0 1730.47 48.8 11.11
Cipla Ltd. 762.35 37.3 61464.46 0.52 571.42 0 4346.16 8.95 3.82
Torrent Pharmaceuticals Ltd. 2711.2 40.6 45884.34 1.18 321 0 2056 1.68 9.51
Lupin Ltd. 998.15 -96.78 45226.17 0.6 108.14 0 3527.86 -20.16 3.59
Cadila Healthcare Ltd. 387.8 29.84 39710.72 0.9 469.9 0 3639.9 4.1 3.39